OptimizeRx Corporation
OPRXNASDAQHealthcare● Active
$5.17
+$0.06(+1.22%)
Market Cap$97060474
P/E Ratio—
52W High$22.25
52W Low$4.57
OptimizeRx Corporation (OPRX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · OPRX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.11B | $0.09B | $0.07B | $0.06B | $0.06B |
| Cost of Revenue | $0.04B | $0.03B | $0.03B | $0.02B | $0.03B |
| Gross Profit | $0.07B | $0.06B | $0.04B | $0.04B | $0.04B |
| Gross Margin %(computed) | 63.30% | 64.45% | 59.98% | 62.40% | 58.14% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.05B | $0.06B | $0.06B | $0.05B | $0.03B |
| Total Operating Expenses | $0.06B | $0.07B | $0.07B | $0.05B | $0.04B |
| Operating Income | $0.01B | ($0.01B) | ($0.03B) | ($0.01B) | $0.00B |
| Operating Margin %(computed) | 11.02% | -14.88% | -36.91% | -19.68% | 0.59% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.01B | ($0.02B) | ($0.03B) | ($0.01B) | $0.00B |
| Income Tax Expense | $0.00B | $0.00B | ($0.01B) | $0.00B | $0.00B |
| Net Income | $0.01B | ($0.02B) | ($0.02B) | ($0.01B) | $0.00B |
| Net Margin %(computed) | 4.69% | -21.83% | -24.56% | -18.32% | 0.62% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.28 | $-1.10 | $-1.03 | $-0.64 | $0.02 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| EBITDA | $0.02B | ($0.01B) | ($0.02B) | ($0.01B) | $0.00B |
| EBITDA Margin %(computed) | 14.98% | -9.66% | -29.79% | -15.08% | 3.80% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more OptimizeRx Corporation data
About OptimizeRx Corporation (OPRX) Income Statement
OptimizeRx Corporation (OPRX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, OPRX reported revenue of $0.11B, gross profit of $0.07B (gross margin 63.30%), and net income of $0.01B — a net profit margin of 4.69%.
Frequently asked questions
OPRX · 4 questionsOptimizeRx Corporation (OPRX) reported revenue of $0.11B for 2025, up 18.8% year-over-year.
OPRX revenueOPRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08